Nobilon International BV, a part of Schering-Plough Corporation, was founded in 2003. It has production and R&D facilities in Boxmeer and Oss, the Netherlands. The biotechnology company is dedicated to develop, produce and commercialize human vaccines, building on existing expertise within Schering-Plough. Nobilon focuses on respiratory, travelers’ and sexually transmitted infections. One of its core expertises is large scale cell culture production of viruses, including influenza.